COR - Cencora Inc. logo

COR

Cencora Inc.

Revenue grew 100% of years5Y
Compare COR Hold

Cencora, Inc. sources and distributes pharmaceuticals, including generic and specialty drugs, over-the-counter products, and healthcare supplies. It serves hospitals, pharmacies, and healthcare providers in the U.S. and internationally.

โš•๏ธ Healthcare NYSE Listed 1995 $ USD
$1,000 invested 5 years ago โ†’$2,690today

Score Overview

1 Year
Score
Net Growth68.89%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth3.56%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score8.0
Net Growth70.45%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth55.51%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth83.82%
Net Trend60%
Net Income Consistency
Rev Growth126.61%
Rev TrendEvery year
Revenue Consistency
20 Years
Score7.1
Net Growth461.20%
Net Trend60%
Net Income Consistency
Rev Growth443.72%
Rev Trend95%
Revenue Consistency
30 Years
Score
Net Growth73x
Net Trend70%
Net Income Consistency
Rev Growth59x
Rev Trend97%
Revenue Consistency
All Time
Score
Net Growth257x
Net Trend71%
Net Income Consistency
Rev Growth71x
Rev Trend97%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Cencora Inc. has ranked, year by year

Measure
Fundamentals Window

Showing all available years ranking history by HDB Score.

Reached the top 50 on HDB Score in 6 years, the longest run being 6 in a row โ€” but not in 2021.

  • COR

2000: 14.5% ยท 2021: 37.6% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 303.81โ€”
1 Year2025-09-26
$ 304.68-0.28%
5 Years2021-09-28
$ 112.94169.00%
10 Years2016-09-28
$ 61.16396.71%
20 Years2006-09-28
$ 12.5024x
30 Years1996-09-27
$ 2.96102x
All Time1995-04-04
$ 1.63186x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 332.77B$ 2.62B$ 2.81B
2025$ 321.33B$ 1.55B$ 4.39B
2024$ 293.95B$ 1.50B$ 3.23B
2023$ 262.17B$ 1.74B$ 2.68B
2022$ 238.58B$ 1.69B$ 3.53B
2021$ 213.98B$ 1.53B$ 2.54B
2020$ 189.89B-$ 3.39B$ 4.59B
2019$ 179.58B$ 855M$ 3.37B
2018$ 167.93B$ 1.65B$ 2.49B
2017$ 153.14B$ 414M$ 2.43B
2016$ 146.84B$ 1.42B$ 2.76B
2015$ 135.96B-$ 134M$ 2.21B
2014$ 119.56B$ 276M$ 1.80B
2013$ 87.95B$ 433M$ 1.23B
2012$ 79.48B$ 718M$ 1.06B
2011$ 80.21B$ 706M$ 1.82B
2010$ 77.95B$ 636M$ 1.65B
2009$ 71.75B$ 503M$ 1.00B
2008$ 70.18B$ 250M$ 878M
2007$ 66.07B$ 469M$ 1.10B
2006$ 61.20B$ 467M$ 1.32B
2005$ 54.57B$ 319M$ 1.31B
2004$ 53.17B$ 468M$ 871M
2003$ 49.65B$ 441M$ 800M
2002$ 45.23B$ 344M$ 663M
2001$ 16.19B$ 125M$ 297M
2000$ 11.64B$ 99M$ 120M
1999$ 9.80B$ 67M$ 59M
1998$ 8.66B$ 50M$ 48M
1997$ 7.81B$ 45M$ 60M
1996$ 5.55B$ 35M$ 65M
IPO1995$ 4.66B$ 10M$ 32M
COR - Cencora Inc. logo

Cencora Inc. fundamental performance

Between 2020 and 2025, revenue grew from $ 189.89B to $ 321.33B and net income went from -$ 3.39B to $ 1.55B. Revenue increased in every one of those 5 years; net income in 4.

Across Cencora Inc.'s full reported history, from 1995 to 2025, revenue grew from $ 4.66B to $ 321.33B and net income grew from $ 10M to $ 1.55B. Revenue increased in 97% of the years measured; net income in 71%.

Cencora Inc. currently holds a 20-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Membership

Continue CORโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies